Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP

Epilepsia

Volumn 51, Issue 8, 2010, Pages 1533-1542

  Chang, Pishan ^a   Chandler, Kate E ^c   Williams, Robin S B ^b   Walker, Matthew C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Hippocampus; Mossy fiber; Protein kinase A; Seizures

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; MAGNESIUM; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PENTETRAZOLE; VALPROIC ACID; ANTICONVULSIVE AGENT; ENZYME INHIBITOR; ISOQUINOLINE DERIVATIVE; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; SULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG MECHANISM; EPILEPSY; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MIGRAINE; MOSSY FIBER; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BRAIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EPILEPSY; ISOQUINOLINES; LONG-TERM POTENTIATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; VALPROIC ACID;

EID: 77955333640     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02412.x     Document Type: Article

References (48)

1. Armand V, Louvel J, Pumain R, Heinemann U 1998) Effects of new valproate derivatives on epileptiform discharges induced by pentylenetetrazole or low Mg2+ in rat entorhinal cortex-hippocampus slices. Epilepsy Res 32:345 355.
2. Boeckeler K, Adley K, Xu X, Jenkins A, Jin T, Williams RSB 2006) The neuroprotective agent, valproic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium discoideum. Eur J Cell Biol 85:1047 1057.
3. Bolanos AR, Sarkisian M, Yang Y, Hori A, Helmers SL, Mikati M, Tandon P, Stafstrom CE, Holmes GL 1998) Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51:41 48.
4. Boulton CL, McCrohan CR, O'Shaughnessy CT 1993) Cyclic AMP analogues increase excitability and enhance epileptiform activity in rat neocortex in vitro. Eur J Pharmacol 236:131 136.
5. Brandt C, Potschka H, Loscher W, Ebert U 2003) N-methyl - aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118:727 740.
6. Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC 1982) Mechanism of anticonvulsant action of valproate. Prog Neurobiol 19:315 359.
7. Chapman AG, Meldrum BS, Mendes E 1983) Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content. Life Sci 32:2023 2031.
8. Chen G, Manji HK, Wright CB, Hawver DB, Potter WZ 1996) Effects of valproic acid on [beta]-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology 15:271 280.
9. Chen HX, Roper SN 2003) PKA and PKC enhance excitatory synaptic transmission in human dentate gyrus. J Neurophysiol 89:2482 2488.
10. Chen Y, Yu FH, Surmeier DJ, Scheuer T, Catterall WA 2006) Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C. Neuron 49:409 420.
11. Cloyd JC, Dutta S, Cao G, Walch JK, Collins SD, Granneman GR 2003) Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy. Epilepsy Res 53:19 27.
12. Couve A, Thomas P, Calver AR, Hirst WD, Pangalos MN, Walsh FS, Smart TG, Moss SJ 2002) Cyclic AMP-dependent protein kinase phosphorylation facilitates GABAB receptor-effector coupling. Nat Neurosci 5:415 424.
13. Covanis A, Gupta AK, Jeavons PM 1982) Sodium valproate: monotherapy and polytherapy. Epilepsia 23:693 720.
14. DeBernardi MA, Brooker G 1996) Single cell Ca2+cAMP cross-talk monitored by simultaneous Ca2+cAMP fluorescence ratio imaging. Proc Natl Acad Sci U S A 93:4577 4582.
15. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK 2004) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578 6589.
16. Ferrendelli JA, Blank AC, Gross RA 1980) Relationships between seizure activity and cyclic nucleotide levels in brain. Brain Res 200:93 103.
17. Gallagher HC, Bacon CL, Odumeru OA, Gallagher KF, Fitzpatrick T, Regan CM 2004) Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression. Neurotoxicol Teratol 26:73 81.
18. Gross RA, Ferrendelli JA 1979) Effects of reserpine, propranolol, and aminophylline on seizure activity and CNS cyclic nucleotides. Ann Neurol 6:296 301.
19. Harris EW, Cotman CW 1986) Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl d-aspartate antagonists. Neurosci Lett 70:132 137.
20. Hattori Y, Moriwaki A, Yasuhara H, Hori Y 1987) Noradrenaline-sensitive cyclic AMP-generating system of rat cerebral cortex with iron-induced epileptiform activity. Jpn J Physiol 37:161 167.
21. Hattori Y, Moriwaki A, Hayashi Y, Hori Y 1993) Involvement of adenosine-sensitive cyclic AMP-generating systems in cobalt-induced epileptic activity in the rat. J Neurochem 61:2169 2174.
22. Higashima M, Ohno K, Koshino Y 2002) Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices. Brain Res 949:157 161. (Pubitemid 35246188)
23. Houslay MD, Kolch W 2000) Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 58:659 668.
24. Huang YY, Li XC, Kandel ER 1994) cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase. Cell 79:69 79.
25. Iwasa H, Kikuchi S, Mine S, Miyagishima H, Sugita K, Sato T, Hasegawa S 2000) Up-regulation of type II adenylyl cyclase mRNA in kindling model of epilepsy in rats. Neurosci Lett 282:173 176.
26. Keane PE, Simiand J, Mendes E, Santucci V, Morre M 1983) The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice. Neuropharmacology 22:875 879. (Pubitemid 13029081)
27. Lamberty Y, Margineanu DG, Klitgaard H 2000) Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav 1:333 342.
28. Lee GY-P, Brown LM, Teyler TJ 1996) The effects of anticonvulsant drugs on long-term potentiation (LTP) in the rat hippocampus. Brain Res Bull 39:39 42.
29. Leweke FM, Louvel J, Rausche G, Heinemann U 1990) Effects of pentetrazol on neuronal activity and on extracellular calcium concentration in rat hippocampal slices. Epilepsy Res 6:187 198.
30. Löscher W, Fisher JE, Nau H, Honack D 1989) Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment. J Pharmacol Exp Ther 250:1067 1078.
31. Löscher W 1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31 59.
32. Mirnikjoo B, Brown SE, Kim HFS, Marangell LB, Sweatt JD, Weeber EJ 2001) Protein kinase inhibition by omega -3 fatty acids. J Biol Chem 276:10888 10896.
33. Montezinho LP, Castro MM, Duarte CB, Penschuck S, Geraldes CFGC, Mork A 2006) The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents. J Neurochem 96:1336 1348.
34. Montezinho LP, Mork A, Duarte CB, Penschuck S, Geraldes CF, Castro MMC 2007) Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D2-like receptors. Bipolar Disord 9:290 297.
35. Moss SJ, Smart TG, Blackstone CD, Huganir RL 1992) Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation. Science 257:661 665.
36. Namkoong S, Kim CK, Cho YL, Kim JH, Lee H, Ha KS, Choe J, Kim PH, Won MH, Kwon YG, Shim EB, Kim YM 2009) Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3KAkteNOS signaling. Cell Signal 21:906 915.
37. Nau H, Zierer R, Spielmann H, Neubert D, Gansau Ch 1981) A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci 29:2803 2814.
38. Nicoll RA, Malenka RC 1995) Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 377:115 118.
39. Salin P, Scanziani M, Malenka R, Nicoll R 1996) Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proc Natl Acad Sci U S A 93:13304 13309.
40. Silver JM, Shin C, McNamara JO 1991) Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 29:356 363.
41. Sokolova S, Schmitz D, Zhang CL, Löscher W, Heinemann U 1998) Comparison of effects of valproate and trans-2-en-valproate on different forms of epileptiform activity in rat hippocampal and temporal cortex slices. Epilepsia 39:251 258.
42. Üre A, Altrup U 2006) Block of spontaneous termination of paroxysmal depolarizations by forskolin (buccal ganglia, Helix pomatia). Neurosci Lett 392:10 15.
43. Weisskopf MG, Castillo PE, Zalutsky RA, Nicoll RA 1994) Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 265:1878 1882.
44. Yechikhov S, Morenkov E, Chulanova T, Godukhin O, Shchipakina T 2001) Involvement of cAMP- and Ca2+calmodulin-dependent neuronal protein phosphorylation in mechanisms underlying genetic predisposition to audiogenic seizures in rats. Epilepsy Res 46:15 25.
45. Yoshino M, Sawada S, Yamamoto C, Kamiya H 1996) A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampus. Neurosci Lett 207:70 72.
46. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G 2001) The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 276:31674 31683.
47. Zalutsky RA, Nicoll RA 1990) Comparison of two forms of long-term potentiation in single hippocampal neurons. Science 248:1619 1624.
48. Zucker RS, Regehr WG 2002) Short-term synaptic plasticity. Annu Rev Physiol 64:355 405.